BlackRock Funds IV - BlackRock Health Sciencs Oppor Port Fd USD Cls K
Name
As of 04/19/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
$71.66
$9.49 B
0.56%
$0.40
0.74%
Vitals
YTD Return
2.3%
1 yr return
4.6%
3 Yr Avg Return
1.1%
5 Yr Avg Return
10.3%
Net Assets
$9.49 B
Holdings in Top 10
41.5%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.74%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 19.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$5,000,000
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 04/19/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
$71.66
$9.49 B
0.56%
$0.40
0.74%
SHSKX - Profile
Distributions
- YTD Total Return 2.3%
- 3 Yr Annualized Total Return 1.1%
- 5 Yr Annualized Total Return 10.3%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio 0.34%
- Dividend Yield 0.6%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameBlackRock Funds IV - BlackRock Health Sciencs Oppor Port Fd USD Cls K
-
Fund Family NameBlackRock
-
Inception DateJun 09, 2016
-
Shares OutstandingN/A
-
Share ClassOther
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerErin Xie
Fund Description
SHSKX - Performance
Return Ranking - Trailing
Period | SHSKX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 2.3% | -28.0% | 10.4% | 19.63% |
1 Yr | 4.6% | -28.0% | 16.9% | 28.83% |
3 Yr | 1.1%* | -35.7% | 10.4% | 38.46% |
5 Yr | 10.3%* | -7.4% | 14.5% | 26.28% |
10 Yr | N/A* | 0.0% | 13.7% | 5.56% |
* Annualized
Return Ranking - Calendar
Period | SHSKX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -0.1% | -12.6% | 19.0% | 69.94% |
2022 | -12.4% | -53.9% | 3.2% | 44.23% |
2021 | 2.4% | -39.6% | 24.2% | 37.82% |
2020 | 14.7% | -13.6% | 178.2% | 43.71% |
2019 | 20.8% | 3.8% | 63.8% | 51.11% |
Total Return Ranking - Trailing
Period | SHSKX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 2.3% | -28.0% | 10.4% | 19.63% |
1 Yr | 4.6% | -28.0% | 16.9% | 28.83% |
3 Yr | 1.1%* | -35.7% | 10.4% | 38.46% |
5 Yr | 10.3%* | -7.4% | 14.5% | 26.28% |
10 Yr | N/A* | 0.0% | 13.7% | 5.43% |
* Annualized
Total Return Ranking - Calendar
Period | SHSKX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 3.9% | -12.6% | 19.0% | 53.37% |
2022 | -5.6% | -53.9% | 3.7% | 25.64% |
2021 | 8.6% | -33.9% | 26.0% | 52.56% |
2020 | 19.9% | -0.7% | 180.6% | 59.60% |
2019 | 25.7% | 4.6% | 63.8% | 49.63% |
NAV & Total Return History
SHSKX - Holdings
Concentration Analysis
SHSKX | Category Low | Category High | SHSKX % Rank | |
---|---|---|---|---|
Net Assets | 9.49 B | 7.41 M | 47.2 B | 4.91% |
Number of Holdings | 150 | 23 | 413 | 9.20% |
Net Assets in Top 10 | 4.17 B | 2.19 M | 20.5 B | 6.13% |
Weighting of Top 10 | 41.45% | 18.1% | 77.0% | 74.85% |
Top 10 Holdings
- UnitedHealth Group Inc 9.44%
- Johnson & Johnson 4.46%
- Eli Lilly and Co 4.02%
- Thermo Fisher Scientific Inc 3.94%
- Pfizer Inc 3.79%
- Abbott Laboratories 3.45%
- AbbVie Inc 3.26%
- Cigna Corp 3.09%
- Danaher Corp 3.05%
- Medtronic PLC 2.98%
Asset Allocation
Weighting | Return Low | Return High | SHSKX % Rank | |
---|---|---|---|---|
Stocks | 96.90% | 87.17% | 106.13% | 68.10% |
Cash | 2.30% | 0.00% | 32.99% | 50.92% |
Other | 0.80% | -22.99% | 17.73% | 15.34% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 44.79% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 27.85% |
Bonds | 0.00% | 0.00% | 12.39% | 31.90% |
Stock Sector Breakdown
Weighting | Return Low | Return High | SHSKX % Rank | |
---|---|---|---|---|
Healthcare | 98.96% | 59.26% | 100.00% | 74.68% |
Basic Materials | 0.73% | 0.00% | 7.16% | 13.92% |
Financial Services | 0.31% | 0.00% | 1.60% | 7.59% |
Utilities | 0.00% | 0.00% | 0.00% | 23.42% |
Technology | 0.00% | 0.00% | 22.69% | 30.38% |
Real Estate | 0.00% | 0.00% | 5.89% | 27.22% |
Industrials | 0.00% | 0.00% | 7.02% | 29.11% |
Energy | 0.00% | 0.00% | 0.00% | 23.42% |
Communication Services | 0.00% | 0.00% | 9.11% | 26.58% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 33.54% |
Consumer Cyclical | 0.00% | 0.00% | 1.92% | 29.11% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | SHSKX % Rank | |
---|---|---|---|---|
US | 90.61% | 66.21% | 104.41% | 62.58% |
Non US | 6.29% | 0.00% | 28.58% | 38.04% |
SHSKX - Expenses
Operational Fees
SHSKX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.74% | 0.08% | 4.28% | 73.01% |
Management Fee | 0.67% | 0.03% | 1.25% | 46.63% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | 0.06% | 0.03% | 0.25% | 10.53% |
Sales Fees
SHSKX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
SHSKX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
SHSKX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 19.00% | 0.00% | 238.00% | 14.49% |
SHSKX - Distributions
Dividend Yield Analysis
SHSKX | Category Low | Category High | SHSKX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.56% | 0.00% | 6.32% | 15.34% |
Dividend Distribution Analysis
SHSKX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annual | Annual | Annual |
Net Income Ratio Analysis
SHSKX | Category Low | Category High | SHSKX % Rank | |
---|---|---|---|---|
Net Income Ratio | 0.34% | -2.54% | 1.85% | 17.31% |
Capital Gain Distribution Analysis
SHSKX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Dec 07, 2023 | $1.400 | OrdinaryDividend |
Dec 09, 2022 | $0.280 | OrdinaryDividend |
Dec 08, 2022 | $0.280 | OrdinaryDividend |
Dec 07, 2020 | $0.190 | OrdinaryDividend |
Dec 06, 2019 | $2.314 | OrdinaryDividend |
Dec 05, 2019 | $0.367 | OrdinaryDividend |
Dec 07, 2018 | $0.284 | OrdinaryDividend |
Dec 05, 2017 | $0.099 | OrdinaryDividend |
SHSKX - Fund Manager Analysis
Managers
Erin Xie
Start Date
Tenure
Tenure Rank
Jul 31, 2003
18.85
18.9%
Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.
Xiang Liu
Start Date
Tenure
Tenure Rank
Jun 01, 2020
2.0
2.0%
Director of BlackRock since 2016. Prior to joining BlackRock in 2008, Mr. Liu was a Partner and Biotech Analyst at Mehta Partners. Mr. Liu began his investment career in 2000 and has a BS from the University of Science & Technology (China), an MBA from the University of Chicago and a PhD degree in Chemistry from Yale University.
Jeff Lee
Start Date
Tenure
Tenure Rank
Jun 01, 2020
2.0
2.0%
Director of BlackRock since 2011. Mr. Lee began his investment career in 2006 and has a BA from Princeton University
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.84 | 0.25 |